Crescent Grove Advisors LLC Sells 77 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Crescent Grove Advisors LLC trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 2.0% in the 4th quarter, Holdings Channel reports. The fund owned 3,700 shares of the healthcare conglomerate’s stock after selling 77 shares during the quarter. Crescent Grove Advisors LLC’s holdings in UnitedHealth Group were worth $1,948,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of UNH. Axiom Financial Strategies LLC purchased a new stake in UnitedHealth Group during the 1st quarter valued at about $210,000. McGowan Group Asset Management Inc. grew its position in UnitedHealth Group by 8.9% during the 1st quarter. McGowan Group Asset Management Inc. now owns 744 shares of the healthcare conglomerate’s stock valued at $379,000 after purchasing an additional 61 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. boosted its holdings in shares of UnitedHealth Group by 31.8% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 250,196 shares of the healthcare conglomerate’s stock valued at $127,592,000 after acquiring an additional 60,300 shares during the last quarter. MAS Advisors LLC boosted its holdings in shares of UnitedHealth Group by 10.8% during the 1st quarter. MAS Advisors LLC now owns 463 shares of the healthcare conglomerate’s stock valued at $241,000 after acquiring an additional 45 shares during the last quarter. Finally, First Western Trust Bank purchased a new stake in shares of UnitedHealth Group during the 1st quarter valued at about $875,000. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Up 1.5 %

Shares of UNH stock traded up $6.43 during trading hours on Monday, reaching $445.63. 5,352,440 shares of the company’s stock were exchanged, compared to its average volume of 4,304,973. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $554.70. The stock has a market cap of $410.84 billion, a PE ratio of 18.74, a PEG ratio of 1.20 and a beta of 0.54. The company has a current ratio of 0.79, a quick ratio of 0.79 and a debt-to-equity ratio of 0.62. The stock’s fifty day moving average price is $492.29 and its two-hundred day moving average price is $516.34.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 EPS for the quarter, beating analysts’ consensus estimates of $5.98 by $0.18. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The firm had revenue of $94.43 billion for the quarter, compared to analyst estimates of $92.13 billion. During the same quarter in the prior year, the firm earned $5.34 earnings per share. UnitedHealth Group’s revenue for the quarter was up 14.1% on a year-over-year basis. Research analysts predict that UnitedHealth Group Incorporated will post 27.7 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were paid a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.69%. UnitedHealth Group’s payout ratio is 31.54%.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on UNH shares. HSBC upgraded shares of UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 price objective on the stock in a research note on Thursday, April 4th. Royal Bank of Canada reiterated an “outperform” rating and issued a $596.00 price objective on shares of UnitedHealth Group in a research note on Thursday, February 29th. TD Cowen decreased their target price on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a research note on Wednesday, April 10th. Oppenheimer restated an “outperform” rating and set a $610.00 target price on shares of UnitedHealth Group in a research note on Wednesday, January 17th. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $591.00 target price on shares of UnitedHealth Group in a research note on Wednesday, April 10th. Three research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Moderate Buy” and an average price target of $573.80.

Insider Transactions at UnitedHealth Group

In related news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. Corporate insiders own 0.35% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.